Bioorganic and Medicinal Chemistry Letters p. 163 - 168 (1997)
Update date:2022-08-03
Topics:
Cherney, Robert J.
Swartz, Stephen G.
Patten, Arthur D.
Akamike, Emeka
Sun, Jung-Hui
Kaltenbach III, Robert F.
Seitz, Steven P.
Behrens, Carl H.
Getahun, Zelleka
Trainor, George L.
Vavala, Mike
Kirshenbaum, Mindy R.
Papp, Lisa M.
Stafford, Margaret P.
Czerniak, Philip M.
Diamond, Richard J.
McRipley, Ronald J.
Page, Roni J.
Gross, Janet L.
Unsymmetrical bis-imides 1 were synthesized and evaluated as potential antitumor agents. These novel bis-imides were assessed using three criteria: in vitro cytotoxicity (L1210), in vitro DNA binding, and in vivo studies with human tumor xenografts in mice. These studies identified DMP 315 as a potent, water soluble antitumor agent.
View MoreWuxi Pharma-Trading Import & Export Co.,Ltd.
Contact:+86-510-82304590 82716390
Address:Room 523,Youzu Alliance Building,No.88 Renmin Zhonglu,Wuxi,Jiangsu,China
KangZhiYuan Pharmaceutical Company Limited
Contact:(Sabrina)86-20-85273232
Address:4th floor, building B, Dadi industry zone, Tangxia, Tianhe, Guangzhou, China
Hangzhou Hysen Pharma co.,Ltd.
website:http://www.hysenpharma.cn/
Contact:0086-571-88298791
Address:#701,Gudun Road Hangzhou
Contact:0571-86821378 ,86820258,56836287,56830923,
Address:Block D ,20F, Tianyuan Building,No.508, Wensan RD, 310013,Hangzhou Zhejiang China
SHANGHAI T&W PHARMACEUTICAL CO., LTD.
website:http://www.trustwe.com
Contact:+86-21-61551611
Address:601, No. 1, 2277 Nong, Zu Chongzhi Road, Zhangjiang Hightech. Park, Pudong
Doi:10.1021/ja00512a045
(1979)Doi:10.13005/ojc/310168
(2015)Doi:10.1039/P19790001729
(1979)Doi:10.1021/ja01500a026
(1960)Doi:10.1007/s11164-015-2373-y
(2016)Doi:10.1016/S0040-4039(01)80784-X
(1989)
